Calithera Biosciences (NASDAQ:CALA) Now Covered by Analysts at StockNews.com

Analysts at StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research report issued to clients and investors on Monday. The firm set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

CALA opened at $0.00 on Monday. Calithera Biosciences has a 12-month low of $0.00 and a 12-month high of $0.12.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.